- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT07615244
STUDY OF MICROVASCULAR DAMAGE IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (MITHO)
The goal of this interventional, non-pharmacological clinical study is to assess microcirculatory dysfunction in patients with thrombotic thrombocytopenic purpura (TTP), both during the acute phase and in remission, compared with the general population.
Microcirculatory damage will be defined as the presence of at least one abnormal instrumental finding among brain magnetic resonance imaging (MRI), optical coherence tomography angiography (OCT-A), and nailfold videocapillaroscopy.
This is a monocentric, national study including two patient cohorts:
Cohort 1: patients enrolled during the acute phase Cohort 2: patients enrolled during remission Participants will be followed for three years with a total of five study visits.
Researchers will not test any drug but will perform detailed clinical, laboratory, and instrumental assessments to evaluate microvascular involvement over time.
Participants will:
- Undergo clinical evaluation, including internal medicine and neurological assessments
- Provide blood and urine samples for laboratory analyses
- Undergo instrumental examinations such as brain MRI, OCT-A, and nailfold videocapillaroscopy
- Receive psychological/neuropsychological evaluations
- Attend follow-up visits over a 3-year period (at baseline, 3 months [cohort 1 only], 12, 24, and 36 months)
Przegląd badań
Status
Interwencja / Leczenie
- Test diagnostyczny: Factor VIII (FVIII)
- Test diagnostyczny: Von Willebrand factor (VWF) antigen
- Test diagnostyczny: VWF:RCo
- Test diagnostyczny: VWF-propeptide
- Test diagnostyczny: VWF multimers
- Test diagnostyczny: sP-selectin
- Test diagnostyczny: sCD40L
- Test diagnostyczny: F1+2
- Test diagnostyczny: VEGF-A
- Test diagnostyczny: VCAM
- Test diagnostyczny: ICAM
- Test diagnostyczny: IL-1β
- Test diagnostyczny: IL-6
- Test diagnostyczny: PTX3
- Test diagnostyczny: BlyS
- Test diagnostyczny: Neutrophil elastase and myeloperoxidase (NETs) markers
- Test diagnostyczny: soluble C5b-9
- Test diagnostyczny: C5a
- Test diagnostyczny: NFL
- Test diagnostyczny: GFAP
- Genetyczny: Whole exome sequencing - WES
- Test diagnostyczny: Proteomic Analysis
- Test diagnostyczny: evaluation of thrombus formation with Total Thrombus formation Analysis System (T-TAS)
- Test diagnostyczny: Microfluidic Flow Chamber
Typ studiów
Zapisy (Szacowany)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Milano
-
Milan, Milano, Włochy, 20122
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dorosły
- Starszy dorosły
Akceptuje zdrowych ochotników
Opis
Inclusion Criteria:
- aged ≥18 years
- with a confirmed diagnosis of TTP (either congenital or acquired immune-mediated TTP)
- referred at our hospital (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) in acute phase of a first or recurrent episode (cohort 1) or referred at our outpatient clinic (S.C. Medicina - Emostasi e Trombosi) during clinical remission at more than 3 months from the clinical response of the previous episode (cohort 2). In any case, patient enrolment will always take place in the S.C. Medicina - Emostasi e Trombosi
- providing a signed informed consent
Exclusion Criteria:
- Patients who do not possess the above inclusion criteria or have known contraindications to the instrumental exam included in the study (MRI).
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Diagnostyczny
- Przydział: Nielosowe
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Inny: Acute TTP
Patients enrolled during acute phase (cohort 1), T0= within 15 days from hospital admission.
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
|
Inny: Remission TTP
Patients enrolled during clinical remission (cohort 2), T0= check-up visit performed at more than 3 months from clinical response of the previous episode
|
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
The study is defined as interventional because it includes assessments that are not part of routine clinical practice
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Prevalence
Ramy czasowe: From enrollment to the last visit (after 36 months from T0)
|
Prevalence of microcirculation damage in iTTP patients compared to general population
|
From enrollment to the last visit (after 36 months from T0)
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Cerebral microcirculation lesions
Ramy czasowe: From enrollment to the last visit (after 36 months from T0)
|
Evaluate cerebral microcirculation lesions (via brain MRI) in both acute and remission phases of TTP to monitor organ damage progression over time
|
From enrollment to the last visit (after 36 months from T0)
|
|
Retinal microcirculation changes
Ramy czasowe: From enrollment to the last visit (after 36 months from T0)
|
Assess retinal microcirculation changes (using OCT and OCT-A) during acute and remission phases of TTP to track organ damage evolution
|
From enrollment to the last visit (after 36 months from T0)
|
|
Peripheral microcirculation
Ramy czasowe: From enrollment to the last visit (after 36 months from T0)
|
Analyze peripheral microcirculation (with nailfold videocapillaroscopy) in acute and remission phases to evaluate progression of organ involvement in TTP
|
From enrollment to the last visit (after 36 months from T0)
|
|
Association between cerebral MRI lesions and cognitive or psychological symptoms
Ramy czasowe: From enrollment to the last visit (36 months from T0)
|
Explore the relationship between cerebral MRI lesions and cognitive or psychological symptoms during TTP remission, assessing symptom progression
|
From enrollment to the last visit (36 months from T0)
|
|
Modification of preclinical biomarkers
Ramy czasowe: From enrollment to the last visit (36 months from T0)
|
Explore the modification of preclinical biomarkers over time at different stage of the disease
|
From enrollment to the last visit (36 months from T0)
|
|
Associations between preclinical biomarkers and microcirculatory damage
Ramy czasowe: From enrollment to the last visit (36 months from T0)
|
Identify associations between preclinical biomarkers and microcirculatory damage in both acute and remission phases of TTP to predict risk and progression
|
From enrollment to the last visit (36 months from T0)
|
Współpracownicy i badacze
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
- Cytopenia
- Procesy patologiczne
- Krwotok
- Manifestacje skórne
- Choroby hematologiczne
- Zaburzenia krzepnięcia krwi
- Zaburzenia płytek krwi
- Mikroangiopatie zakrzepowe
- Plamica, małopłytkowość
- Plamica
- Małopłytkowość
- Trombofilia
- Stany patologiczne, oznaki i objawy
- Objawy i symptomy
- Choroby hemowe i limfatyczne
- Purpura, zakrzepowa małopłytkowość
- Techniki śledcze
- Techniki genetyczne
- Analiza sekwencji
- Analiza sekwencji, DNA
- Sekwencjonowanie całego genomu
- Sekwencjonowanie egzomów
Inne numery identyfikacyjne badania
- IRCCSMaggioreH (IRCCSMaggioreH)
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na TTP - zakrzepowa plamica małopłytkowa
-
TakedaJeszcze nie rekrutacjaZakrzepowa plamica małopłytkowa (TTP)
-
TakedaJeszcze nie rekrutacja
-
Assistance Publique - Hôpitaux de ParisRekrutacyjnyChoroby układu krążenia | Choroby Autoimmunologiczne | Mikroangiopatie zakrzepowe | Rzadkie choroby | Zakrzepowa plamica małopłytkowa (TTP) | Objawy neurologiczne | Odporność zakrzepowa trombocytopeniczna purpura | Mikroangiopatia, choroba zakrzepkowaFrancja
-
BloodworksUniversity of WashingtonZakończonyPurpura, zakrzepowa małopłytkowość | TTPStany Zjednoczone
-
The First Affiliated Hospital of Soochow UniversityRekrutacyjny
-
University College, LondonRekrutacyjnyTTP - zakrzepowa plamica małopłytkowaZjednoczone Królestwo
-
University College, LondonZakończonyZakrzepowa plamica małopłytkowa (TTP)Zjednoczone Królestwo
-
Turkish Hematology AssociationSanofiRekrutacyjnyTTP - zakrzepowa plamica małopłytkowaIndyk
-
TakedaZatwierdzony do celów marketingowychZakrzepowa plamica małopłytkowa (TTP)
-
OctapharmaZakończonyZakrzepowa plamica małopłytkowa (TTP)Stany Zjednoczone
Badania kliniczne na Factor VIII (FVIII)
-
BayerZakończonyHemofilia AStany Zjednoczone
-
Baxalta now part of ShireZakończony
-
Grifols Biologicals, LLCAktywny, nie rekrutującyChoroba von Willebranda
-
Hoffmann-La RocheChugai PharmaceuticalZakończonyHemofilia AAustralia, Tajwan, Republika Korei, Francja, Niemcy, Włochy, Afryka Południowa, Hiszpania, Stany Zjednoczone, Japonia, Irlandia, Polska, Zjednoczone Królestwo, Kostaryka
-
Hospices Civils de LyonZakończony
-
Fondazione Angelo Bianchi BonomiSintesi Research SrlZakończonyHemofilia AStany Zjednoczone, Indie, Hiszpania, Argentyna, Austria, Brazylia, Chile, Egipt, Iran (Islamska Republika, Włochy, Meksyk, Arabia Saudyjska, Afryka Południowa, Indyk
-
Dhaka Medical CollegeJeszcze nie rekrutacja
-
Federico II UniversityZakończony
-
Chulalongkorn UniversityZakończony